Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia

• Principais autores: Fu-rong Liu (Autor), Hui Jin (Autor), Yin Wang (Autor), Chen Chen (Autor), Ming Li (Autor), Sheng-jun Mao (Autor), Qiantao Wang (Autor), Hui Li (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

A novel niosomal delivery system was designed and investigated for the targeted delivery of daunorubicin (DNR) against acute myeloid leukemia (AML). Anti-CD123 antibodies conjugated to Mal-PEG2000-DSPE were incorporated into normal niosomes (NS) via a post insertion method to afford antibody-modifie...